Perioperative Chemotherapy for Liver Metastasis of Colorectal Cancer.
colorectal cancer
liver metastasis
neoadjuvant/adjuvant chemotherapy and conversion chemotherapy
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
26 Nov 2020
26 Nov 2020
Historique:
received:
04
10
2020
revised:
28
10
2020
accepted:
12
11
2020
entrez:
1
12
2020
pubmed:
2
12
2020
medline:
2
12
2020
Statut:
epublish
Résumé
The liver is the dominant site of metastasis for patients with colorectal cancer. For those with isolated liver metastases, surgical resection with systemic therapy has led to long-term remission in as high as 80% of patients in well-selected cohorts. This review will focus on how systemic therapy should be integrated with resection of liver metastases; in particular, the use of clinical risk scores based on clinicopathological features that help with patient selection, various approaches to the treatment of micro-metastatic disease (peri-operative versus post-operative chemotherapy), as well as conversion chemotherapy for those with initially upfront unresectable disease will be discussed.
Identifiants
pubmed: 33256170
pii: cancers12123535
doi: 10.3390/cancers12123535
pmc: PMC7760826
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
JAMA. 2017 Jun 20;317(23):2392-2401
pubmed: 28632865
World J Gastroenterol. 2006 Oct 21;12(39):6305-9
pubmed: 17072953
Ann Surg. 1999 Sep;230(3):309-18; discussion 318-21
pubmed: 10493478
Int J Colorectal Dis. 2017 Aug;32(8):1179-1190
pubmed: 28424871
J Clin Oncol. 2006 Nov 1;24(31):4976-82
pubmed: 17075115
Cancer. 1996 Apr 1;77(7):1254-62
pubmed: 8608500
Oncologist. 2018 Jan;23(1):128-134
pubmed: 28904173
Liver Int. 2009 Jan;29(1):89-102
pubmed: 18673436
Lancet Oncol. 2014 May;15(6):601-11
pubmed: 24717919
J Clin Oncol. 2007 May 1;25(13):1670-6
pubmed: 17470860
Lancet Oncol. 2013 Oct;14(11):1077-1085
pubmed: 24028813
Ann Surg. 2004 Dec;240(6):1052-61; discussion 1061-4
pubmed: 15570210
J Clin Oncol. 2008 Oct 20;26(30):4906-11
pubmed: 18794541
Lancet Oncol. 2013 Nov;14(12):1208-15
pubmed: 24120480
J Gastrointest Oncol. 2019 Dec;10(6):1183-1192
pubmed: 31949938
Ann Oncol. 2005 Mar;16(3):425-9
pubmed: 15677624
J Natl Cancer Inst. 2020 Apr 15;:
pubmed: 32294214
N Engl J Med. 2004 Jun 3;350(23):2335-42
pubmed: 15175435
Cancer Epidemiol. 2014 Aug;38(4):448-54
pubmed: 24841870
Lancet. 2008 Mar 22;371(9617):1007-16
pubmed: 18358928
Br J Cancer. 2011 Mar 1;104(5):856-62
pubmed: 21285991
J Clin Oncol. 2013 Jun 1;31(16):1931-8
pubmed: 23569301
World J Surg. 1995 Jan-Feb;19(1):59-71
pubmed: 7740812
Lancet Oncol. 2014 Sep;15(10):1065-75
pubmed: 25088940
BMC Cancer. 2009 Apr 22;9:120
pubmed: 19386096
Ann Oncol. 2014 Jan;25(1):107-16
pubmed: 24356622
J Clin Oncol. 2005 Dec 20;23(36):9243-9
pubmed: 16230673
Clin Cancer Res. 2019 Oct 1;25(19):5843-5851
pubmed: 31221662
Ann Oncol. 2014 Jul;25(7):1346-1355
pubmed: 24718886
J Clin Oncol. 2008 Apr 10;26(11):1830-5
pubmed: 18398148
Ann Oncol. 2015 Apr;26(4):702-708
pubmed: 25538173
J Clin Oncol. 2005 Nov 20;23(33):8490-9
pubmed: 16230676
Neoplasia. 2017 Feb;19(2):93-99
pubmed: 28088688
Clin Exp Metastasis. 2015 Jun;32(5):457-65
pubmed: 25899064
Ann Surg. 2004 Jun;239(6):818-25; discussion 825-7
pubmed: 15166961
JAMA. 2011 Feb 2;305(5):487-94
pubmed: 21285426
BMC Cancer. 2014 Nov 04;14:810
pubmed: 25369977
J Clin Oncol. 2008 Nov 20;26(33):5344-51
pubmed: 18936472
Ann Surg. 2004 Oct;240(4):644-57; discussion 657-8
pubmed: 15383792
Ann Oncol. 2011 Sep;22(9):2042-2048
pubmed: 21285134
J Clin Oncol. 2018 Oct 30;:JCO2018789032
pubmed: 30376428
Ann Surg Oncol. 2015 Aug;22(8):2761-71
pubmed: 25572686
Ann Surg Oncol. 2015 Dec;22(13):4158-65
pubmed: 26077912
Eur J Cancer. 2017 Mar;73:74-84
pubmed: 27986363
Cancer. 2014 Aug 1;120(15):2316-24
pubmed: 24737664
Lancet Oncol. 2010 Jan;11(1):38-47
pubmed: 19942479
Cancer Chemother Pharmacol. 2008 Jul;62(2):195-201
pubmed: 17901955
Sci Rep. 2019 Oct 25;9(1):15365
pubmed: 31653970
N Engl J Med. 2009 Apr 2;360(14):1408-17
pubmed: 19339720
JAMA Oncol. 2016 May 1;2(5):643-653
pubmed: 26768652
J Clin Oncol. 2008 Nov 20;26(33):5320-1
pubmed: 18936470
Ann Surg. 1997 Jan;225(1):51-60; discussion 60-2
pubmed: 8998120
Lancet Oncol. 2020 Mar;21(3):324-326
pubmed: 32014120
J Surg Oncol. 2005 Sep 1;91(3):173-80
pubmed: 16118771
Lancet Oncol. 2014 Jul;15(8):862-73
pubmed: 24928083
Ann Oncol. 2009 Apr;20(4):674-80
pubmed: 19179549
Cancer. 1998 May 15;82(10 Suppl):2057-60
pubmed: 9587107
Br J Cancer. 2007 Oct 22;97(8):1035-9
pubmed: 17895897
Br J Surg. 2018 Aug;105(9):1210-1220
pubmed: 29691844
Cells. 2019 May 28;8(6):
pubmed: 31142037
JAMA. 2012 Apr 4;307(13):1383-93
pubmed: 22474202
Ann Oncol. 2016 Aug;27(8):1386-422
pubmed: 27380959
J Clin Oncol. 2006 May 1;24(13):2065-72
pubmed: 16648507
Cancer Chemother Pharmacol. 2013 Jul;72(1):223-30
pubmed: 23689915
Ann Oncol. 2017 Aug 1;28(8):1713-1729
pubmed: 28407110
Lancet Oncol. 2010 Sep;11(9):845-52
pubmed: 20702138
N Engl J Med. 2014 Oct 23;371(17):1609-18
pubmed: 25337750
HPB (Oxford). 2011 Nov;13(11):774-82
pubmed: 21999590
J Clin Oncol. 2005 Jun 1;23(16):3697-705
pubmed: 15738537
Oncologist. 2020 Jul;25(7):e1031-e1041
pubmed: 32181531
J Clin Oncol. 2009 Feb 10;27(5):663-71
pubmed: 19114683
J Clin Oncol. 2010 Nov 1;28(31):4697-705
pubmed: 20921465
Ann Oncol. 2016 Sep;27(9):1746-53
pubmed: 27358379
Br J Cancer. 2015 Jun 9;112(12):1921-8
pubmed: 25942399
Ann Oncol. 2009 Dec;20(12):1964-70
pubmed: 19567451
JAMA Surg. 2018 Jul 18;153(7):e180996
pubmed: 29799910
Ann Surg. 2006 Jan;243(1):1-7
pubmed: 16371728
J Clin Oncol. 2008 Apr 20;26(12):2013-9
pubmed: 18421054
JAMA Oncol. 2017 Jul 13;3(7):e170278
pubmed: 28542671
Lancet Oncol. 2020 Mar;21(3):398-411
pubmed: 32014119
J Clin Oncol. 2006 Aug 20;24(24):3939-45
pubmed: 16921046
Ann Oncol. 2004 Jun;15(6):933-9
pubmed: 15151951
J Clin Oncol. 2013 Jan 20;31(3):359-64
pubmed: 23233715